CUTANEOUS GENE THERAPY - 10/09/11

Doi : 10.1016/S0733-8635(05)70412-5

Paul A. Khavari, MD, PhD ^{^{*
From the Dermatology Service, Veterans Administration Palo Alto Health Care System, Palo Alto (PAK); and the Department of Dermatology, Stanford University, Stanford (PAK), California; and the Department of Dermatology, Utah Health Sciences Center, Salt Lake City, Utah (GGK)}}, Gerald G. Krueger, MD ^{^{*
From the Dermatology Service, Veterans Administration Palo Alto Health Care System, Palo Alto (PAK); and the Department of Dermatology, Stanford University, Stanford (PAK), California; and the Department of Dermatology, Utah Health Sciences Center, Salt Lake City, Utah (GGK)}}

Mappa

CANDIDATE DISEASES

EX VIVO GENE TRANSFER TO THE SKIN

GENE TRANSFER METHODS

IN VIVO GENE THERAPY

KEY CHALLENGES

EXPERIMENTAL MODEL SYSTEMS

SAFETY

CONCLUSION

Address reprint requests to Paul A. Khavari, MD, PhD Dermatology Service Veterans Administration Palo Alto 3801 Miranada Palo Alto, CA 94304

Esportazione

Vol 15 - N° 1

P. 27-35 - gennaio 1997 Ritorno al numero

Articolo precedente

ADVANCES IN CHEMICAL PEELING
William P. Coleman, Harold J. Brody

| Articolo seguente

CLINICAL UPDATES IN HAIR
Marty E. Sawaya

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

connettersi o creare un account

CUTANEOUS GENE THERAPY - 10/09/11

Mappa

Citazioni Export

File

Contenuto

Il mio account

Aide & support

Dichiarazione CNIL